700 patients110,866 observations180 daysLIVE

Patient P-02158

Synthetic patientMETA-24 · Day 169 · 65–74 · M · baseline S20Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
18%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S20
  2. Day 14 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 14.

Primary contributors, last 14 days
  • GI instability-7
  • Toxicity+6
  • Treatment adherence-5
  • Inflammatory activity-4
  • Nutritional resilience+4

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    68 min
    worsening · -5.0 vs previous 14 d
    Sleep duration
    Wearable
    6.6 h
    stable · -0.1 vs previous 14 d
    Energy level
    Daily log
    4.8/10
    worsening · -0.8 vs previous 14 d
    Steps
    Wearable
    8,308
    worsening · -342 vs previous 14 d
    GI burden
    Companion
    23.3/100
    worsening · +8.8 vs previous 14 d
    Adherence
    Companion
    88.6 %
    stable · -2.8 vs previous 14 d
    Sleep quality
    Wearable
    36.1/100
    worsening · -4.0 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    137 mg/dL
    stable · +3.6 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards restoration · 62 from the failing basin, 36 from restoration.

    Would help
    • No untried action with strong evidence. Compose one from primitives.
    • More protein
      GI -5.6 next day on high-intake days · n 24
    Would not help
    • Keep histamine low
      GI +4.1 next day on high-intake days · n 18
    • Keep fat low
      GI +3.9 next day on high-intake days · n 18
    • Keep ultra-processed low
      GI +3.7 next day on high-intake days · n 13
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -5.6supporter · 95%
    • Histamine load
      +4.1detractor · 95%
    • Dietary fat load
      +3.9detractor · 95%
    • Ultra-processed food
      +3.7detractor · 80%
    • Simple carbohydrates
      +3detractor · 80%
    • Alcohol
      -2.2no signal · 52%
    • Caffeine
      -0.9no signal · 21%
    • Insoluble fibre
      +0.6no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production 60
      • MicrobiomeButyrate capacity 38/100
      • MicrobiomeF. prausnitzii depleted
    • Inflammatory signalling 35
      • MicrobiomeBacteroides fragilis expansion
      • WearableHRV 36 ms, trending down
    • Mucosal barrier integrity 30
      • DNAFUT2 non-secretor lowers mucosal fucosylation
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.1 · butyrate capacity 38/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    37 ms
    Sleep
    6.7 h
    Steps
    7,774
    Resting HR
    58 bpm
    Daily log: GI score 23, nutritional resilience 65, adherence 89.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0256842%S0151
    P-0227639%S0157
    P-0259839%S0153
    P-0230738%S0155
    P-0208737%S01BR-03no change40
    P-0221837%S01DT-01improved61
    P-0252236%S01BR-03no change40
    P-0268136%S0151
    P-0204134%S0127
    P-0243734%S0164
    P-0255034%S0170
    P-0221733%S0161